UnitedHealth Group (NYSE:UNH) Rating Reiterated by BMO Capital Markets

UnitedHealth Group (NYSE:UNH)‘s stock had its “market perform” rating reaffirmed by stock analysts at BMO Capital Markets in a note issued to investors on Wednesday, The Fly reports. They presently have a $310.00 price objective on the healthcare conglomerate’s stock. BMO Capital Markets’ target price would suggest a potential upside of 11.20% from the stock’s current price.

Other analysts also recently issued research reports about the stock. Cantor Fitzgerald boosted their price objective on shares of UnitedHealth Group from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday. Barclays upped their target price on shares of UnitedHealth Group from $260.00 to $305.00 and gave the company an “overweight” rating in a report on Monday. Credit Suisse Group increased their target price on shares of UnitedHealth Group from $293.00 to $320.00 and gave the company an “outperform” rating in a research report on Wednesday. Piper Jaffray Companies lifted their price target on shares of UnitedHealth Group from $312.00 to $325.00 and gave the stock an “overweight” rating in a research note on Wednesday. Finally, Mizuho reissued a “buy” rating and issued a $300.00 price target (up from $270.00) on shares of UnitedHealth Group in a research report on Tuesday, November 26th. Seven equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $299.35.

Shares of UNH opened at $278.77 on Wednesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.70. UnitedHealth Group has a 1 year low of $208.07 and a 1 year high of $283.00. The stock has a market capitalization of $264.70 billion, a PE ratio of 21.64, a P/E/G ratio of 1.48 and a beta of 0.64. The company’s 50-day simple moving average is $260.30 and its 200-day simple moving average is $245.75.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.75 by $0.13. The business had revenue of $60.35 billion during the quarter, compared to analysts’ expectations of $59.84 billion. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the previous year, the company earned $3.41 EPS. On average, sell-side analysts predict that UnitedHealth Group will post 14.96 earnings per share for the current year.

In other news, EVP D Ellen Wilson sold 7,400 shares of the stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $272.77, for a total transaction of $2,018,498.00. Also, CAO Thomas E. Roos sold 1,177 shares of the stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $255.04, for a total transaction of $300,182.08. Following the sale, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 38,577 shares of company stock worth $9,398,080. 0.82% of the stock is currently owned by company insiders.

Hedge funds have recently modified their holdings of the stock. Selective Wealth Management Inc. purchased a new position in UnitedHealth Group in the 3rd quarter valued at $27,000. North Star Investment Management Corp. acquired a new position in UnitedHealth Group in the 3rd quarter valued at $30,000. Delta Asset Management LLC TN raised its position in UnitedHealth Group by 111.0% during the 3rd quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 81 shares during the last quarter. Fusion Family Wealth LLC raised its position in UnitedHealth Group by 329.7% during the 3rd quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 122 shares during the last quarter. Finally, Massey Quick Simon & CO. LLC raised its position in UnitedHealth Group by 212.5% during the 3rd quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock worth $38,000 after buying an additional 119 shares during the last quarter. Hedge funds and other institutional investors own 85.50% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: What Are Cryptocurrencies?

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit